Amneal appoints deborah m. autor to board of directors

Bridgewater, n.j.--(business wire)--amneal pharmaceuticals, inc. (nyse: amrx) (“amneal” or the “company”) today announced that deborah m. autor has been appointed to the company's board of directors, effective july 29, 2022. chirag and chintu patel, co-chief executive officers, stated, “deb brings decades of global public and private expertise in the biopharmaceutical sector to our board at an important time of growth for amneal. she has a proven track record of service and impact throughout he
AMRX Ratings Summary
AMRX Quant Ranking